Target intelligence / Profile preview

Retinaldehyde-binding protein 1 (Cellular retinaldehyde-binding protein) (RLBP1)

Target
RLBP1
Molecular classification
Carrier protein
01

Overview

Retinaldehyde-binding protein 1 (RLBP1), also known as cellular retinaldehyde-binding protein (CRALBP), is a 36 kDa soluble protein abundantly expressed in the retinal pigment epithelium (RPE), Müller cells, and photoreceptors, where it functions as a carrier for retinoids such as 11-cis-retinal and 11-cis-retinol. It plays a critical role in the visual cycle by facilitating the regeneration of light-sensitive 11-cis-retinal from all-trans-retinal products of rhodopsin photocycle, enabling proper rod and cone photoreceptor function. CRALBP binds retinoids stereoselectively in a hydrophobic pocket, promoting their transport, enzymatic isomerization, and delivery while preventing non-specific diffusion or toxicity. Mutations disrupting retinoid binding, such as R234W or R150Q, impair visual cycle efficiency and cause autosomal recessive retinal dystrophies including retinitis pigmentosa, Bothnia dystrophy, retinitis punctata albescens, and fundus albipunctatus. The protein is also detected in brain oligodendrocytes and other tissues without endogenous retinoids, hinting at additional physiological roles. No drugs directly target CRALBP, and its study relies on recombinant models mirroring native structure and ligand interactions.

Other names
CRALBP
02

Biological functions

Retinoid metabolismVisual pigment regenerationVisual cycle
03

Disease associations

Retinitis pigmentosaBothnia dystrophyRetinitis punctata albescensFundus albipunctatus

Beyond the preview

Go deeper on Retinaldehyde-binding protein 1 (Cellular retinaldehyde-binding protein) (RLBP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinaldehyde-binding protein 1 (Cellular retinaldehyde-binding protein) (RLBP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call